Metabolic risks and effects of atypical antipsychotic treatment.

The Journal of clinical psychiatry

Volumn 68, Issue 10, 2007, Pages

  Haupt, Dan W ^a   Kane, John M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; EXTRAPYRAMIDAL SYNDROME; HUMAN; MEDICAL EDUCATION; OBESITY; PATIENT COMPLIANCE; RISK FACTOR; SCHIZOPHRENIA; STATISTICS;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; EDUCATION, MEDICAL, CONTINUING; HUMANS; OBESITY; PATIENT COMPLIANCE; RISK FACTORS; SCHIZOPHRENIA;

MLCS; MLOWN;

EID: 38449111884     PISSN: None     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/jcp.1007e24     Document Type: Article

References (0)